Published in Gut on May 01, 1989
Bifidobacterium lactis DSM 10140: identification of the atp (atpBEFHAGDC) operon and analysis of its genetic structure, characteristics, and phylogeny. Appl Environ Microbiol (2004) 1.14
Helicobacter pylori requires TlpD-driven chemotaxis to proliferate in the antrum. Infect Immun (2012) 0.98
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
Regional postprandial differences in pH within the stomach and gastroesophageal junction. Dig Dis Sci (2005) 0.95
Detailed in vivo analysis of the role of Helicobacter pylori Fur in colonization and disease. Infect Immun (2010) 0.91
The ion sensitive field effect transistor (ISFET) pH electrode: a new sensor for long term ambulatory pH monitoring. Gut (1991) 0.86
Role of energy sensor TlpD of Helicobacter pylori in gerbil colonization and genome analyses after adaptation in the gerbil. Infect Immun (2013) 0.82
Acidic digestion in a teleost: postprandial and circadian pattern of gastric pH, pepsin activity, and pepsinogen and proton pump mRNAs expression. PLoS One (2012) 0.82
Postprocessing in vitro digestion challenge to evaluate survival of Escherichia coli O157:H7 in fermented dry sausages. Appl Environ Microbiol (2004) 0.80
Comparison of gastric body and antral pH. Gut (1989) 0.75
Disturbed fibrinolysis in patients with inflammatory bowel disease. Gut (1989) 0.75
Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol (1984) 10.23
Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest (1973) 5.31
Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol (1986) 4.95
Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. Gastroenterology (1985) 2.34
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Duodenogastric reflux in humans: its relationship to fasting antroduodenal motility and gastric, pancreatic, and biliary secretion. Gastroenterology (1981) 1.76
Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut (1987) 1.70
Alkaline reflux gastritis: a critical reappraisal. Gut (1984) 1.47
Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut (1983) 1.25
Determinants of delayed gastric emptying in anorexia nervosa and bulimia nervosa. Gut (1988) 1.04
Characteristics of reflux gastritis. Scand J Gastroenterol (1987) 0.95
Duodenogastric reflux. Gut (1983) 0.87
[Continuous intragastric pH-metry]. Schweiz Med Wochenschr (1985) 0.85
[Diagnostic value of gastric pHmetry in duodenogastric reflux]. Gastroenterol Clin Biol (1987) 0.82
An endoscopic procedure for accurate localisation of intraluminal pH electrodes. Endoscopy (1987) 0.82
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Incidence and nature of bile duct injuries following laparoscopic cholecystectomy: an audit of 5913 cases. West of Scotland Laparoscopic Cholecystectomy Audit Group. Br J Surg (1996) 4.61
Oral cimetidine in severe duodenal ulceration. A double-blind controlled trial. Lancet (1977) 3.95
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology (2001) 3.52
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology (1995) 3.28
Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology (1997) 3.16
Alosetron in irritable bowel syndrome. Lancet (2000) 2.94
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol (1999) 2.89
Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology (1999) 2.53
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
The Glasgow Dyspepsia Severity Score--a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol (1996) 2.19
Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery. Ann R Coll Surg Engl (2013) 2.17
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut (1993) 2.05
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology (1993) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology (2000) 1.74
Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol (1991) 1.72
The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature (2001) 1.71
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71
Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet (1989) 1.70
An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology (1969) 1.68
Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut (1991) 1.66
Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology (1969) 1.65
Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut (1993) 1.64
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60
Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology (1994) 1.50
Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut (1999) 1.50
Choledocholithiasis--in vivo stone dissolution using methyl tertiary butyl ether (MTBE). Gut (1988) 1.44
Comment on article by Oksüzoglu et al. Endoscopy (1998) 1.37
Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology (2000) 1.33
Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations. Gut (1991) 1.31
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut (1994) 1.28
Helicobacter pylori utilises urea for amino acid synthesis. FEMS Immunol Med Microbiol (1996) 1.26
Computer interrogation of patients. Br Med J (1976) 1.25
Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut (1989) 1.23
Early outcome after open versus extraperitoneal endoscopic tension-free hernioplasty: a randomized clinical trial. Surgery (1996) 1.21
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19
Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut (1994) 1.19
Effects of cimetidine on carbamazepine auto- and hetero-induction in man. Br J Clin Pharmacol (1984) 1.19
Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet (1982) 1.15
Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects. Scand J Gastroenterol (1992) 1.14
Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut (1991) 1.13
The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology (1998) 1.12
Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology (1996) 1.12
Studies in the rates of epithelial cell exfoliation from the gastric mucosa in normal and in ulcer subjects. Gut (1971) 1.12
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol (1999) 1.10
The porphyrias: an example of pharmacogenetic disease. Scott Med J (1981) 1.09
Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol (1997) 1.08
Orthostatic hypotension in bronchial carcinoma. Br Med J (1972) 1.07
Electrodes for 24 hours pH monitoring--a comparative study. Gut (1987) 1.06
A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut (1995) 1.05
A combined TDDA-PVC pH and reference electrode for use in the upper small intestine. J Med Eng Technol (1990) 1.04
Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol (1993) 1.04
Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut (1993) 1.04
Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology (1999) 1.03
Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut (1991) 1.02
Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol (1992) 1.01
Comparison of helisal rapid blood test and 14C-urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients. Am J Gastroenterol (1998) 0.99
Effect of rifampicin on haem and bilirubin metabolism in man. Br J Clin Pharmacol (1987) 0.98
Duodenal ulcer pain--the role of acid and inflammation. Gut (1993) 0.98
Hepatocellular and gastric carcinoma associated with familial polyposis coli. J Surg Oncol (1988) 0.96
Measurement of urea and ammonium concentrations in gastric juice. J Clin Pathol (1993) 0.96
Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium. J Clin Pathol (1991) 0.95
Taking a calculated risk: predictive scoring systems in dyspepsia. Scand J Gastroenterol Suppl (1987) 0.95
The effect of vagotomy on the lower part of the acid dose-response curve to pentagastrin in man. Clin Sci (1972) 0.95
"Ulcer--like dyspepsia". Scand J Gastroenterol Suppl (1982) 0.95
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma. Ann Oncol (2002) 0.95
The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Br J Cancer (2012) 0.94
Hyperplasia of the gastric mucosa produced by duodenal obstruction. Gastroenterology (1969) 0.93
Effect of hypophysectomy on the gastric mucosa of the rat. Gut (1968) 0.93
Comparison of an enzyme immunoassay for the detection of Helicobacter pylori antigens in the faeces with the urea breath test. Arch Dis Child (2000) 0.93
Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg (2002) 0.93
Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur J Clin Invest (1980) 0.92
Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria. Clin Sci (Lond) (1982) 0.92
Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation. Scand J Gastroenterol (1992) 0.91
In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand J Gastroenterol (2002) 0.91
Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection. Gut (1992) 0.90
Early-onset chronic renal failure as a complication of acute intermittent porphyria. Q J Med (1983) 0.90
The acute porphyrias. Br J Clin Pract (1993) 0.89
Lack of certainty on the diagnosis of acute intermittent porphyria: comment on the concise communication by Cohen et al. Arthritis Rheum (1998) 0.89
Smoking and recurrent attacks of acute intermittent porphyria. BMJ (1991) 0.88
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma. Ann Oncol (2001) 0.88
Problems associated with the clinical use of proton pump inhibitors. Pharmacol Toxicol (2001) 0.87
Bilateral posterior dislocation of the shoulder. Injury (1985) 0.86
Helicobacter pylori in the faeces? QJM (1999) 0.86
Chester porphyria: biochemical studies of a new form of acute porphyria. Lancet (1985) 0.86
The effects of vagotomy on the gastric mucosa of the rat. Scand J Gastroenterol (1969) 0.86
Suicidal destruction of Helicobacter pylori: metabolic consequence of intracellular accumulation of ammonia. J Clin Pathol (1991) 0.86
A study of the acid dose-response curve to small doses of pentagastrin in duodenal ulcer patients. Clin Sci (1972) 0.85
Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses. BMJ (1999) 0.85
Alcohol and porphyria. Lancet (1981) 0.85
Preliminary communication of the effect of Gastrin II on acid secretion in conscious rats with chronic gastric fistula. Gastroenterologia (1966) 0.84
Hypertension and renal impairment as complications of acute porphyria. Nephrol Dial Transplant (1992) 0.83
Management of attacks of acute porphyria. Drugs (1987) 0.83